Condition
Clinical Stage IV Cutaneous Melanoma AJCC v8 clinical trials and research
As of November 12, 2026, Find a Trial lists 13 Clinical Stage IV Cutaneous Melanoma AJCC v8 clinical trials that are recruiting, in United States. By phase: Phase 2 (5), Phase 1 (4), Phase 1/2 (3). The most active sponsors are Mayo Clinic (3), M.D. Anderson Cancer Center (3), Ohio State University Comprehensive Cancer Center (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 13Clinical trials
- 1Country
Newest Clinical Stage IV Cutaneous Melanoma AJCC v8 clinical trials
All recruiting trials (13)
-
Time-of-day immunotherapy for advanced melanoma
This trial tests whether giving the immune drugs ipilimumab and nivolumab in the morning rather than later in the day helps people with unresectable or metastatic melanoma respond better.
-
Comparing home and clinic administration of nivolumab for cancer treatment
This study tests whether giving cancer patients their treatment at home instead of in a clinic makes them feel better and prefer their care more.
-
Monitoring T Cell Responses in Cancer Patients Receiving Anti-PD-1 Therapy
This study is trying to see how T cells in the blood can help doctors understand how well anti-PD-1 therapy works for people with melanoma, lung cancer, and other cancers.
-
Combining immunotherapy with prednisone and sirolimus for kidney transplant recipients with advanced skin cancer
This study is testing a new treatment that combines two immunotherapy drugs with prednisone and sirolimus to see if it helps kidney transplant recipients with advanced skin cancer while keeping their transplanted kidney safe.
-
Natural Killer Cell Therapy and Temozolomide for Stage IV Melanoma with Brain Metastasis
This study is testing a new treatment combining special immune cells and a cancer drug to see if it helps people with advanced melanoma that has spread to the brain.
-
Personalized vaccine combined with pembrolizumab for advanced solid tumors
This study is testing a new personalized cancer vaccine combined with pembrolizumab to see if it helps people with advanced solid tumors fight their cancer better.
-
Combining cabozantinib and nivolumab to treat advanced melanoma and head and neck cancer
This study is testing a combination of two cancer drugs, cabozantinib and nivolumab, to see if they can help people with advanced melanoma or head and neck cancer while also looking at how to better match treatments to patients based on their tumor characteristics.
-
Personalized vaccine treatment for advanced melanoma, breast cancer, and lung cancer
This study is testing a personalized vaccine combined with a treatment called nivolumab to see if it can help people with advanced melanoma, breast cancer, or lung cancer fight their tumors better.
-
Treatment of advanced solid tumors with IACS-6274 and other medications
This study is testing a new drug called IACS-6274, alone and with other medications, to see how well it can help people with advanced solid tumors and what the safest dose is.
-
Treatment of metastatic melanoma with binimetinib and encorafenib
This study is testing if a combination of two medications can help people with a specific type of melanoma that has spread to the brain feel better and live longer.
-
Using an influenza vaccine to treat melanoma
This study is testing whether an influenza vaccine can safely help people with melanoma, a type of skin cancer, by seeing how well it works to shrink tumors and improve their condition.
-
Comparing two treatment combinations for melanoma with brain metastases
This study is testing two different treatment combinations for patients with melanoma that has spread to the brain to see which one helps them live longer without the disease getting worse.
-
Exploring gut microbiome and fecal transplant effects on GI issues in cancer patients
This study is testing how the gut bacteria affect stomach issues in cancer patients receiving certain treatments and whether a stool transplant can help relieve those problems.
Related topics
Quick answers
How many Clinical Stage IV Cutaneous Melanoma AJCC v8 clinical trials are recruiting right now?
13, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 5, Phase 1: 4, Phase 1/2: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.